Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Milazzo

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Genes|December 23, 2022
Single-Cell Sequencing Identifies Master Regulators Affected by Panobinostat in Neuroblastoma CellsGiorgio Milazzo, Giovanni Perini, Federico M Giorgi
Cell Death and Differentiation|October 15, 2016
Letting the breaks off MYCNGiovanni Perini, Giorgio Milazzo, Nisha Narayan, et al.
Frontiers in Microbiology|June 2, 2015
Growth of Rhodococcus sp. strain BCP1 on gaseous n-alkanes: new metabolic insights and transcriptional analysis of two soluble di-iron monooxygenase genesMartina Cappelletti, Alessandro Presentato, Giorgio Milazzo, et al.
Genes|May 21, 2020
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological ActionabilityGiorgio Milazzo, Daniele Mercatelli, Giulia Di Muzio, et al.
Oncotarget|June 12, 2015
Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastomaStefano Amente, Giorgio Milazzo, Maria Cristina Sorrentino, et al.
Cancer Letters|April 7, 2015
SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastomaLaura Evans, Lindi Chen, Giorgio Milazzo, et al.
International Journal of Molecular Sciences|December 10, 2021
Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic DrugsRoberto Ciaccio, Piergiuseppe De Rosa, Sara Aloisi, et al.
International Journal of Molecular Sciences|March 29, 2023
<i>MYCN</i> Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors' Efficacy in Neuroblastoma CellsPiergiuseppe De Rosa, Federica Severi, Suleman Khan Zadran, et al.
Oncotarget|July 26, 2018
Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastomaSaurabh Agarwal, Giorgio Milazzo, Kimal Rajapakshe, et al.
Oncotarget|May 15, 2018
MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastomaSaurabh Agarwal, Giorgio Milazzo, Kimal Rajapakshe, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Genes|December 23, 2022
Single-Cell Sequencing Identifies Master Regulators Affected by Panobinostat in Neuroblastoma CellsGiorgio Milazzo, Giovanni Perini, Federico M Giorgi
Cell Death and Differentiation|October 15, 2016
Letting the breaks off MYCNGiovanni Perini, Giorgio Milazzo, Nisha Narayan, et al.
Frontiers in Microbiology|June 2, 2015
Growth of Rhodococcus sp. strain BCP1 on gaseous n-alkanes: new metabolic insights and transcriptional analysis of two soluble di-iron monooxygenase genesMartina Cappelletti, Alessandro Presentato, Giorgio Milazzo, et al.
Genes|May 21, 2020
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological ActionabilityGiorgio Milazzo, Daniele Mercatelli, Giulia Di Muzio, et al.
Oncotarget|June 12, 2015
Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastomaStefano Amente, Giorgio Milazzo, Maria Cristina Sorrentino, et al.
Cancer Letters|April 7, 2015
SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastomaLaura Evans, Lindi Chen, Giorgio Milazzo, et al.
International Journal of Molecular Sciences|December 10, 2021
Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic DrugsRoberto Ciaccio, Piergiuseppe De Rosa, Sara Aloisi, et al.
International Journal of Molecular Sciences|March 29, 2023
<i>MYCN</i> Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors' Efficacy in Neuroblastoma CellsPiergiuseppe De Rosa, Federica Severi, Suleman Khan Zadran, et al.
Oncotarget|July 26, 2018
Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastomaSaurabh Agarwal, Giorgio Milazzo, Kimal Rajapakshe, et al.
Oncotarget|May 15, 2018
MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastomaSaurabh Agarwal, Giorgio Milazzo, Kimal Rajapakshe, et al.
Pageof 3